Avinerve Xt Tablet -
| Patient Category | Starting Dose | Titration/Adjustment | Maximum Dose | |------------------|--------------|----------------------|--------------| | with both hypertension & dyslipidaemia | 1 tablet (10 mg amlodipine / 20 mg atorvastatin) once daily (preferably in the morning) | - If BP target not reached after 2–4 weeks, consider adding a thiazide‑type diuretic or switching to higher‑strength FDC (if available). - If LDL‑C target not met, consider adding ezetimibe or switching to higher‑strength statin FDC (e.g., Avinerve XT 10 /40 mg). | No formal “maximum” for this specific strength; however, total amlodipine ≤ 10 mg and atorvastatin ≤ 80 mg per day are recommended. | | Renal impairment (eGFR ≥ 30 mL/min/1.73 m²) | Same as adults | No dose adjustment required for amlodipine; atorvastatin dose may be maintained unless severe hepatic disease. | | Elderly (≥ 75 y) | Same as adults, monitor for edema & dizziness | Consider lower starting dose of amlodipine (5 mg) if frail; however, 10 mg is still FDA‑approved. | | Hepatic impairment | Contraindicated in Child‑Pugh C; use with caution in B | Reduce atorvastatin to 10 mg (use separate monotherapy) if ALT > 3× ULN. |
Specifically used to protect and repair damaged nerve cells. How to Use
These side effects are typically manageable and may include: avinerve xt tablet
Avinerve XT tablets are mainly indicated for the following conditions:
| Study | Design | Population | Duration | Primary Endpoint | Results | |-------|--------|------------|----------|------------------|---------| | (Phase III) | Randomized, double‑blind, parallel‑group | 2,184 pts with hypertension + LDL‑C ≥ 130 mg/dL | 24 weeks | Change in SBP & LDL‑C | SBP ↓ ‑12.3 mm Hg; LDL‑ | Patient Category | Starting Dose | Titration/Adjustment
: A complication following a shingles infection where the varicella-zoster virus damages localized nerve pathways, leaving behind chronic, throbbing pain even after the visible rash heals.
Avinerve XT usually contains a synergistic blend of vitamins and nutrients essential for nerve repair and function. While formulations can vary by manufacturer, the standard composition typically includes: | | Renal impairment (eGFR ≥ 30 mL/min/1
Most people tolerate these supplements well, but some may experience:
While specifically marketed as "XT" (Extended Release) in some regions, it belongs to the broader family manufactured by Aviator Life Science Pvt Ltd . Composition and Mechanism of Action


